NCT00907478View on ClinicalTrials.gov

Study on Bone Marrow Morphology in Adults Receiving Romiplostim for Treatment of Thrombocytopenia Associated With Immune Thrombocytopenia Purpura (ITP)

PHASE4CompletedINTERVENTIONAL
Enrollment

169

Participants

Timeline

Start Date

August 11, 2009

Primary Completion Date

January 9, 2014

Study Completion Date

January 14, 2014

Conditions
ThrombocytopeniaIdiopathic Thrombocytopenic Purpura
Interventions
BIOLOGICAL

romiplostim

Romiplostim administered by subcutaneous injection

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY

NCT00907478 - Study on Bone Marrow Morphology in Adults Receiving Romiplostim for Treatment of Thrombocytopenia Associated With Immune Thrombocytopenia Purpura (ITP) | Biotech Hunter | Biotech Hunter